Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology.
about
Optimal treatment and stochastic modeling of heterogeneous tumorsResearch progress in the radioprotective effect of the canonical Wnt pathwayPhase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904.Feasibility of dose painting using volumetric modulated arc optimization and delivery.A validated tumor control probability model based on a meta-analysis of low, intermediate, and high-risk prostate cancer patients treated by photon, proton, or carbon-ion radiotherapy.Optimization of the fractionated irradiation scheme considering physical doses to tumor and organ at risk based on dose-volume histograms.Optimization of radiation dosing schedules for proneural glioblastoma.The biological effectiveness of targeted radionuclide therapy based on a whole-body pharmacokinetic model.Simultaneous optimization of dose distributions and fractionation schemes in particle radiotherapyAn Estimation of Radiobiological Parameters for Head-and-Neck Cancer Cells and the Clinical Implications.Optimal weekly scheduling in fractionated radiotherapy: effect of an upper bound on the dose fraction size.Optimal number and sizes of the doses in fractionated radiotherapy according to the LQ model.Improving the therapeutic ratio in stereotactic radiosurgery: optimizing treatment protocols based on kinetics of repair of sublethal radiation damage.A feasibility study of dynamic adaptive radiotherapy for nonsmall cell lung cancer.Optimal fractionation in radiotherapy with multiple normal tissues.Optimal solution for a cancer radiotherapy problem.A feasibility study: Selection of a personalized radiotherapy fractionation schedule using spatiotemporal optimization.Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines.
P2860
Q26739901-5754C673-BA4D-4AA6-A70D-0ACEF62DD90AQ28386021-53CEEC66-649F-4E37-8AF3-5DB0EA80BD2AQ33627751-6869EFC4-6D33-4024-8AF7-EDB10A88864DQ34662439-FB7FE51B-D02B-435D-8804-86A588732BB7Q38722286-41FFDA31-3C59-40D4-9DDB-1FA9BB222F59Q40370986-985D9EF3-4AEF-4965-BD1F-98FB01A53A42Q40816691-FF07D7EA-1BC1-44F3-9FDD-E05F11D50653Q42010261-CA040BBA-9046-447E-A08F-1B705AD3E4F9Q42566159-A2120756-393A-4918-B7BF-C11A4F5736E5Q43089932-5DF93297-42A5-4EDF-AB9B-F1F2DF328ADAQ47439697-0DA111FE-1974-432A-8163-858E8308A22CQ47560995-B169A451-4477-4D8E-9787-012387918628Q48145212-FFB21836-2054-49F2-8A1D-8C3AF5F2A1A9Q50652930-27D4F556-006D-4E04-9D32-12E998F96392Q50912967-992C2E1B-3AA4-493B-BDAD-FC0E480F35F3Q51428132-53B7FE37-84C9-4A22-8FF2-206702AF5E50Q51664383-938E4BD6-61DF-4626-9FA9-4006A98F597BQ52911914-7810040C-2A2C-4DD1-BD33-2636D12DE2E6
P2860
Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Optimization of radiotherapy d ...... ion of tumor specific biology.
@en
Optimization of radiotherapy d ...... ion of tumor specific biology.
@nl
type
label
Optimization of radiotherapy d ...... ion of tumor specific biology.
@en
Optimization of radiotherapy d ...... ion of tumor specific biology.
@nl
prefLabel
Optimization of radiotherapy d ...... ion of tumor specific biology.
@en
Optimization of radiotherapy d ...... ion of tumor specific biology.
@nl
P2860
P356
P1433
P1476
Optimization of radiotherapy d ...... ion of tumor specific biology.
@en
P2093
P2860
P304
P356
10.1118/1.2126167
P407
P577
2005-12-01T00:00:00Z